Sale!

CEBPA Gene Leukemia Myeloid Acute Form Due to CEBPA Germline Mutation NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CEBPA Gene Leukemia NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies germline mutations in the CEBPA gene, which are responsible for familial acute myeloid leukemia (AML). This comprehensive next-generation sequencing test provides crucial information for individuals with family history of leukemia or unexplained blood disorders. The test analyzes the complete CEBPA gene sequence to detect inherited mutations that significantly increase leukemia risk. Results are delivered within 3-4 weeks from blood or DNA samples. Priced at $500 USD, this test offers vital insights for cancer prevention and personalized treatment planning. Genetic counseling is included to help interpret results and understand familial implications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CEBPA Gene Leukemia Myeloid Acute Form Due to CEBPA Germline Mutation NGS Genetic DNA Test

Comprehensive Genetic Testing for Familial Acute Myeloid Leukemia

The CEBPA Gene Leukemia NGS Genetic DNA Test represents a breakthrough in genetic cancer screening, specifically designed to identify inherited mutations in the CEBPA gene that predispose individuals to acute myeloid leukemia (AML). This sophisticated diagnostic tool utilizes next-generation sequencing technology to provide comprehensive analysis of germline mutations, offering critical insights for cancer risk assessment and prevention strategies.

What Does This Test Measure and Detect?

This advanced genetic test specifically targets and analyzes the CEBPA (CCAAT/enhancer-binding protein alpha) gene, which plays a crucial role in normal blood cell development and differentiation. The test detects:

  • Germline mutations in the CEBPA gene associated with familial AML
  • Specific genetic variants that disrupt normal hematopoietic function
  • Inherited predisposition to acute myeloid leukemia development
  • Genetic markers that influence treatment response and prognosis
  • Mutations that may be passed to future generations

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals who exhibit the following risk factors or symptoms:

  • Family history of acute myeloid leukemia or blood disorders
  • Unexplained fatigue, weakness, or frequent infections
  • Easy bruising or unusual bleeding tendencies
  • Recurrent fever or night sweats without apparent cause
  • Bone pain or tenderness
  • Unexplained weight loss or loss of appetite
  • Individuals with previous abnormal blood counts
  • Those planning family who have leukemia in their family history

Clinical Benefits of CEBPA Gene Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Early Risk Identification: Detect genetic predisposition before symptoms develop
  • Personalized Surveillance: Implement targeted monitoring for at-risk individuals
  • Family Planning Guidance: Understand inheritance patterns and risks for offspring
  • Treatment Optimization: Inform therapeutic decisions based on genetic profile
  • Proactive Prevention: Enable early intervention and preventive measures
  • Psychological Relief: Provide clarity and reduce uncertainty about genetic risks

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our certified genetic counselors. Possible outcomes include:

  • Positive Result: Indicates the presence of a CEBPA germline mutation, confirming increased leukemia risk and enabling proactive management
  • Negative Result: No detected mutation, significantly reducing concern for inherited AML predisposition
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing monitoring and research

All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps.

Test Pricing and Details

Test Component Details
Test Name CEBPA Gene Leukemia Myeloid Acute Form Due to CEBPA Germline Mutation NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.

Take Control of Your Genetic Health Today

Don’t let uncertainty about your genetic cancer risk affect your peace of mind. Our comprehensive CEBPA gene testing provides the clarity you need to make informed health decisions. With expert genetic counseling included and results delivered within 3-4 weeks, you can take proactive steps toward managing your health and protecting your family’s future.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your CEBPA Gene Leukemia NGS Test. Our certified genetic specialists are ready to guide you through every step of the testing process and help you understand your results with compassion and expertise.